Search research articles
Contact Us
Filters
Showing results (221-230 of 242) with videos related to
Page
of 25
Sort By:
Terapevticheskii Arkhiv
|
October 26, 2022
[Masks hiding mitochondrial neurogastrointestinal encephalomyopathy. Case report]
I V Maev, E V Kolmakova, S N Bardakov, et al.
Terapevticheskii Arkhiv
|
October 26, 2022
[Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management]
I G Bakulin, M I Skalinskaya, I V Maev, et al.
Terapevticheskii Arkhiv
|
August 30, 2025
[Study on the efficacy of combination therapy with rifaximin and <i>Saccharomyces boulardii</i> CNCM I-745 in patients with small intestinal bacterial overgrowth associated with long-term use of proton pump inhibitors]
I V Maev, D N Andreev, R I Shaburov, et al.
Bulletin of Experimental Biology and Medicine
|
October 25, 2017
Design of Nanosomal Form of Aprotinin
O A Kulikov, N A Pyataev, A V Zaborovskii, et al.
Terapevticheskii Arkhiv
|
March 16, 2016
[Specific features of the enteric microbiota composition in patients with alcoholic liver cirrhosis]
N V Shalikiani, I G Bakulin, V B Dubinkina, et al.
Terapevticheskii Arkhiv
|
April 16, 2025
[Trends of antibiotic resistance of Helicobacter pylori in Moscow]
I V Maev, D N Andreev, A K Fomenko, et al.
Terapevticheskii Arkhiv
|
December 21, 2020
[Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results]
I V Maev, D N Andreev, V M Govorun, et al.
Terapevticheskii Arkhiv
|
October 26, 2022
[Multicenter study of gastroesophageal reflux disease symptoms prevalence in outpatients in Russia]
D S Bordin, R А Abdulkhakov, M F Osipenko, et al.
Terapevticheskii Arkhiv
|
February 1, 2019
Effectiveness of mebeverine in patients with post-cholecystectomy gastrointestinal spasm: results of prospective observational program "odyssey"
I V Maev, Yu A Kucheravy, V V Tsukanov, et al.
Terapevticheskii Arkhiv
|
May 24, 2024
[Study of the resistome of human microbial communities using a targeted panel of antibiotic resistance genes in COVID-19 patients]
O O Yanushevich, I V Maev, N I Krikheli, et al.
Page
of 25
Search research articles
Search
Showing results (221-230 of 242) with videos related to
Sort By:
Page
of 25
Terapevticheskii Arkhiv
|
October 26, 2022
[Masks hiding mitochondrial neurogastrointestinal encephalomyopathy. Case report]
I V Maev, E V Kolmakova, S N Bardakov, et al.
Terapevticheskii Arkhiv
|
October 26, 2022
[Pharmacotherapy of inflammatory bowel diseases: efficacy performance and safety management]
I G Bakulin, M I Skalinskaya, I V Maev, et al.
Terapevticheskii Arkhiv
|
August 30, 2025
[Study on the efficacy of combination therapy with rifaximin and <i>Saccharomyces boulardii</i> CNCM I-745 in patients with small intestinal bacterial overgrowth associated with long-term use of proton pump inhibitors]
I V Maev, D N Andreev, R I Shaburov, et al.
Bulletin of Experimental Biology and Medicine
|
October 25, 2017
Design of Nanosomal Form of Aprotinin
O A Kulikov, N A Pyataev, A V Zaborovskii, et al.
Terapevticheskii Arkhiv
|
March 16, 2016
[Specific features of the enteric microbiota composition in patients with alcoholic liver cirrhosis]
N V Shalikiani, I G Bakulin, V B Dubinkina, et al.
Terapevticheskii Arkhiv
|
April 16, 2025
[Trends of antibiotic resistance of Helicobacter pylori in Moscow]
I V Maev, D N Andreev, A K Fomenko, et al.
Terapevticheskii Arkhiv
|
December 21, 2020
[Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results]
I V Maev, D N Andreev, V M Govorun, et al.
Terapevticheskii Arkhiv
|
October 26, 2022
[Multicenter study of gastroesophageal reflux disease symptoms prevalence in outpatients in Russia]
D S Bordin, R А Abdulkhakov, M F Osipenko, et al.
Terapevticheskii Arkhiv
|
February 1, 2019
Effectiveness of mebeverine in patients with post-cholecystectomy gastrointestinal spasm: results of prospective observational program "odyssey"
I V Maev, Yu A Kucheravy, V V Tsukanov, et al.
Terapevticheskii Arkhiv
|
May 24, 2024
[Study of the resistome of human microbial communities using a targeted panel of antibiotic resistance genes in COVID-19 patients]
O O Yanushevich, I V Maev, N I Krikheli, et al.
Page
of 25